U.S., Jan. 21 -- ClinicalTrials.gov registry received information related to the study (NCT03535883) titled 'The Safety of Thoracentesis, Tunneled Pleural Catheter, and Chest Tubes in Patients Taking Novel Oral Anti-Coagulants' on May 8, 2018.
Brief Summary: To assess risks of bleeding in those individuals receiving Novel Oral Anti-Coagulant (NOAC) medications, admitted to the hospital and require thoracentesis, chest tube or tunneled pleural catheter placement.
Study Type: Observational
Condition: * Pleural Effusion
* Thoracic Effusion
Intervention: Drug: Novel Oral Anti-Coagulants
Novel Oral Anti-Coagulant (NOAC) medications (i.e. Eliquis, Plavix, Xarelto etc.)
Other Name: NOAC
Recruitment Status: Recruiting
Sponsor: Yale Univers...